Xylem exceeded expectations in Q1 2025, posting growth in revenue and earnings, supported by healthy demand, operating discipline, and strategic pricing actions.
Revenue reached $2.1 billion, growing 2% year-over-year.
Reported EPS was $0.69; adjusted EPS was $1.03, up 14%.
Net income rose to $169 million, with an 8.2% net income margin.
First-quarter adjusted EBITDA margin expanded by 120 basis points to 20.4%.
Xylem reaffirmed its full-year 2025 guidance, expecting stable revenue growth and margin expansion despite market volatility.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance